Although PXDN overexpression correlates with poor prognosis in several carcinomas [9–12], and its prognostic value in NPC has been recently documented [13], the functional mechanisms through which PXDN promotes aggressiveness, and the regulatory basis for its overexpression in NPC, remain largely unknown. This evidence concerns the gene PXDN and carcinoma.